In 2018 the FDA initiated a recall of the generic blood pressure medication Valsartan after it was discovered that many lots of the drug were contaminated with the cancer-causing substance N-Nitrosodimethylamine (NDMA). NDMA is a byproduct of a chemical reaction that occurs during the manufacturing process of Valsartan when the atmosphere is too acidic.
Similarly, Zantac (or ranitidine) has been found to be tainted with the same chemical - NDMA. Low levels of exposure may not be harmful, but the FDA has required manufacturers to conduct testing on all ranitidine and nizatidine products. Any lots with elevated levels of NDMA - above 96 nanograms per day or 0.32 parts per million for ranitidine - should not be released to consumers.
If you or a loved one has been diagnosed with the following cancers after using Valsartan for high blood pressure, or Zantac (ranitidine) for heartburn, contact the product liability attorneys at Egerton Law today for a consultation about your legal rights. Our North Carolina attorneys can help you determine whether you have a claim for compensation.
NDMA has been linked to:
Small intestine cancer